SuiGeneris collaborates with Dr B Barooah Cancer Institute on anti-Cancer research
Source: The Sangai Express

Imphal, September 07 2021: Manipur based CC Tea manufactured by SuiGeneris Agronomy Private Limited has inked a three year anti-cancer research collaboration with Dr B Barooah Cancer Institute to assess the efficacy of CC Tea extract on molecular pathways in lymphocytes and other blood cells of cancer patients of North East India.

The three phase research undertaking will begin with CC Tea extract being tested on blood cells taken from cancer patients to test the effect of the extracts on the patients directly, said a statement issued by SuiGeneris Agronomy Private Limited.

The company recently concluded a 6 months antiviral and immunomodulatory research with the prestigious Indian Institute of Technology, Guwahati and have found that CC Tea showed high anti-viral activity to the Japanese Encephalitis Virus (JEV) and Newcastle Disease Virus (NDV) .

It also suggests positive innate immune activation in gene analysis.

Ragesh Keisham, Chairman & CEO of SuiGeneris Agronomy Private Limited said, "Over the years, we have received encouraging feedback from our users on various health related benefits after prolonged use of CC Tea.

A recent Govt study found that North East is the cancer capital of India and this research collaboration with Dr B Barooah Cancer Institute, Guwahati is a proof of our commitment for a relentless fight against Cancer" .

CC Tea is one of the fastest growing companies in Manipur and is being sold in the North East Region and across India through the e-commerce site and through retail channels.

Dr B Barooah Cancer Institute is a premier institution involved in quality medical research and healthcare.

The Institute was formally taken over by the Department of Atomic Energy, Govt of India on 27th November 2017 as a unit of Tata Memorial Centre, Mumbai.

Comment